Molecular Cancer
-
Publication Venue For
- Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway.. 18:107. 2019
- N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.. 18:11. 2019
- MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.. 14:67. 2015
- Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma.. 12:80. 2013
- Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck.. 11:17. 2012
- EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: a potential mechanism of EGFR-driven antagonism of apoptosis.. 10:26. 2011
- Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.. 9:289. 2010
- Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.. 9:98. 2010
- A conserved acidic patch in the Myb domain is required for activation of an endogenous target gene and for chromatin binding.. 7:77. 2008
- hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands.. 6:37. 2007
- Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH.. 4:39. 2005
- RNA-binding proteins to assess gene expression states of co-cultivated cells in response to tumor cells.. 3:24. 2004